Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A patient's perspective of partnership in the treatment of multiple sclerosis: MS regimes-An orchestrated approach.
Multiple sclerosis rehabilitation.
Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.
Testosterone Depletion Increases the Susceptibility of Brain Tissue to Oxidative Damage in a Restraint Stress Mouse Model.
Differential Diagnosis for Multiple Sclerosis-related Optic Neuritis.
Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Proton detection for signal enhancement in solid-state NMR experiments on mobile species in membrane proteins.
Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Multiple sclerosis: Natalizumab to fingolimod-the washout whitewash.
Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.
Defining a role for laquinimod in multiple sclerosis.
Transverse myelitis due to Staphylococcus aureus may occur without contiguous spread.
A 39 years old woman responding to modafinil with bilateral hypothalamic lesion associated with hyperthermia and hypersomnia: a case report.
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.
Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Acute transverse myelitis in childhood: A single centre experience from North India.
Established disease-modifying treatments in relapsing-remitting multiple sclerosis.
Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors.
[Towards a nursing consultation in neurosexology].
Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs.
Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?
Does Infection-Induced Immune Activation Contribute to Dementia?
Pages
« first
‹ previous
…
494
495
496
497
498
499
500
501
502
…
next ›
last »